Research ArticleCellular and Molecular
Adenylate cyclase-cAMP-protein kinase A signaling pathway inhibits endothelin type A receptor-operated Ca2+ entry mediated via TRPC6 channels.
Takahiro Horinouchi, Tsunaki Higa, Hiroyuki Aoyagi, Tadashi Nishiya, Koji Terada and Soichi Miwa
Journal of Pharmacology and Experimental Therapeutics October 14, 2011, jpet.111.187500; DOI: https://doi.org/10.1124/jpet.111.187500
Takahiro Horinouchi
Tsunaki Higa
Hiroyuki Aoyagi
Tadashi Nishiya
Koji Terada

Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCellular and Molecular
Adenylate cyclase-cAMP-protein kinase A signaling pathway inhibits endothelin type A receptor-operated Ca2+ entry mediated via TRPC6 channels.
Takahiro Horinouchi, Tsunaki Higa, Hiroyuki Aoyagi, Tadashi Nishiya, Koji Terada and Soichi Miwa
Journal of Pharmacology and Experimental Therapeutics October 14, 2011, jpet.111.187500; DOI: https://doi.org/10.1124/jpet.111.187500
Research ArticleCellular and Molecular
Adenylate cyclase-cAMP-protein kinase A signaling pathway inhibits endothelin type A receptor-operated Ca2+ entry mediated via TRPC6 channels.
Takahiro Horinouchi, Tsunaki Higa, Hiroyuki Aoyagi, Tadashi Nishiya, Koji Terada and Soichi Miwa
Journal of Pharmacology and Experimental Therapeutics October 14, 2011, jpet.111.187500; DOI: https://doi.org/10.1124/jpet.111.187500
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement